Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Pediastrip
- Development stage
- Unknown
- Lead developer
- Cure Pharmaceuticals
- Modality
- Device-based Delivery → Drug Delivery Systems
- Administration
- Oral
01
Overview
**Pediastrip** is a private-label electrolyte oral thin-film product reported to have been sold through major drugstore chains. It uses a rapidly dissolving oral-film delivery format intended to provide electrolyte supplementation without a conventional tablet, capsule, or liquid dosage form. Public descriptions associate its development with CURE Pharmaceutical's oral thin-film technology work, but do not disclose a product-specific electrolyte composition, labeled clinical indication, regulatory status, or biological target. ([drug-dev.com](https://drug-dev.com/oral-thin-films-the-quest-for-a-magic-pill-may-not-be-a-pill-at-all/))
- Brand names
- Pediastrip
Beyond the preview
Go deeper on Pediastrip.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Pediastrip.